|

YTS109 cell Clinical Trials

5 actively recruiting trials

Pipeline

Phase 1: 5

Top Sponsors

  • China Immunotech (Beijing) Biotechnology Co., Ltd.5

Indications

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis5
  • Inflammatory Myopathy5
  • Lupus5
  • Systemic Lupus Erythematosus (SLE)4
  • Lupus Nephritis (LN)3

Other5 trials

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Phase 1
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.